Key facts
- Notable investors include Company Ventures, Riot Ventures, Freeflow Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Mango (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Mango (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mango (Biotechnology)
Developer of a microbial quality control testing platform intended to monitor cell growth in real time. The company's platform offers computer vision technology and an image analysis platform that detects microbial growth in hours with the manual petri dish monitoring process, enabling users to speed up the time-to-market for pharmaceutical products, thereby reducing contaminant risk and waste.
- Sector
- Healthcare
- HQ
- Medford, MA, United States
- Founded
- 2018
- Website
- mangodx.com/
- Ownership
- Privately Held (backing)
Mango (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mango (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mango (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.